Based on that hypotheses and previous findings, we investigated the effects of αCD137 for NK cell activation to up-regulate Tmab-mediated ADCC against HER2-low-expressing human pancreatic carcinoma cell lines as part of efforts to establish a new regimen for unresectable human pancreatic carcinoma. This evidence concerns the gene ERBB2 and exocrine pancreatic carcinoma.